By: Daniel Trecroci
Running the Gamut
FDA Approves Alternate-Site Testing
for All Bayer Meters
Bayer Diagnostics announced on May 28, 2002, that the U.S. Food and Drug Administration has approved the use of its complete line of blood-glucose meters for alternate-site testing.
According to a company news release, Bayer is now “the only company to offer alternate-site testing across its range of self-test monitors.”
The meters now approved for forearm, palm, abdomen and thigh testing include the Glucometer Elite, the Glucometer Elite XL, and the Glucometer DEX/DEX 2 systems.
For more information, call